Mikael Lindström
About me
PhD degree in Experimental Oncology 2004 and Docent in Experimental Pathology
- obtained 2012 at Karolinska Institutet i Stockholm, Sweden.
Research
We are specifically interested in molecular mechanisms underlying the regulation of ribosome biogenesis, how the cell senses errors in the complex process of ribosome biogenesis and how these processes in turn can be used in the development of novel anti-cancer therapies. To investigate ribosome biogenesis and nucleolar structure, the team uses various microscopy technologies, ribosome profiling, rDNA assays, transcriptomics, translatomics, and proteomics. We also work a lot with small molecules and functional screens. Main lines and interests of research: 1. Characterization of ribosome biogenesis regulatory proteins and potential role in cancer development, biomarker discovery for precision /
personalized cancer medicine. 2. Regulation of ribosome biogenesis and protein synthesis in normal CNS cells and in glioma, including heterogeneity of ribosome in relation to glioma cellular diversity. 3. Targeting of ribosome biogenesis or mature ribosome function in cancer. 4. Functional studies of ribosomal proteins.I have evaluated manuscripts for the following journals among others
Oncogene, Nature, EMBO Rep, EMBO J, Nature Cell Biology, J Biol Chem, Mol Cell Biol, Proteins, J. of Clinical Investigation, Mol Cell, Intl. J of Cancer, Int J Mol Sciences, Cancer, Cancers, J Cytology &
- Histology, J Mol Biol, PLoS One, FEBS Letters, FEBS J, Future Oncology, Cell Proliferation, Biochem J, Scientific Reports, Tumor Biology, Current Drug Targets, Cytotherapy, Nature Communications, J Cell Science, Cell Reports, Cell Cycle, Chemistry Biology, Blood, Pharmaceuticals, Biochem Soc Trans, Cells, Oncotarget, Int J of Dev Neuroscience, Cellular Physiology and Biochemistry, BMC Biotechnology, BMC Molecular Biology, Bioscience Reports, Cancer Res, Elife, J Cellular Physiology, J Oncology, BBA Mol Cell, Comm Biol, Metabolites, Ebiomedicine, ACS Chemical Biology, BBA Molecular Res, Biomarkers, JCI Insight, BioEssays, Cell Death and Disease, Cell Death and Differentiation, Biomedicines, Breast Cancer Research, Pathogens, Signal Transduction and Targeted Therapies, Biomolecules and Biomedicine, Histology &
- Histopathology, Epigenetics and Chromatin, Mol Oncol, Nucleic Acids Res Cancer, iScience, Int J Cancer, Discover Oncology, Trends Cell Biology, Cell Proliferation and many others
Teaching
Supervision
Co-supervisor: Dr Tamador Elsir, PhD 2010-06-04, KI
Co-supervisor: Dr Inga Nazarenko, PhD 2011-09-30, KI
Co-supervisor: Dr Karl Holmberg-Olausson, PhD 2015-06-01, KIMain supervisor: Dr Kaveh Moazemi Goudarzi, PhD 2018-04-27, KI
Main supervisor: Dr Asimina Zisi, PhD 2022-10-28, KIService to the universities
Pre-examiner of doctoral dissertation: 16 (2009-2024)
Half time review for PhD: 20 (2012-2024)
Chairman of PhD defense: 8 (2015-2024)
Examiner of MSc or BSc thesis 16 (2012-2018)
Opponent: 1Following courses I have taken
Basic pedagogics for university lecturers GHPH09
Postgraduate supervisor training course KI
Leadership education UGL, KI
Web courses for supervisors
I have over 1000 teaching hours in cell biology, oncology, and biochemistry for students at the medical and biomedical programs, including molecular oncology and biostatistics (BioMed), and Molecular Medicine course, cell biology. At the medical program biochemistry in the DFM1 and BV2 courses. I have been teaching also at the postgraduate course level, at the Cancer Cell cycles and Cancer Cell metabolism courses. I have co-organized a course on Brain Tumors. I currently also teach biochemistry at the KI "prep course" for foreign (non EU) medical doctors that will take knowledge test for licence to practice medicine in Sweden.
Articles
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2024;52(8):4151-4166
- Journal article: CANCER RESEARCH. 2024;84(6):4526
- Journal article: CANCER RESEARCH. 2024;84(5):pr-002-pr-002
- Article: CELL DEATH AND DIFFERENTIATION. 2023;30(7):1666-1678
- Article: NEURO-ONCOLOGY. 2023;25(6):1058-1072
- Article: ONCOGENE. 2021;40(32):5066-5080
- Article: SCIENCE ADVANCES. 2021;7(32):eabf7561
- Article: CANCER RESEARCH. 2020;80(7):1538-1550
- Article: CELL DEATH AND DIFFERENTIATION. 2020;27(2):773-789
- Article: NEURO-ONCOLOGY ADVANCES. 2020;2(1):vdaa061
- Article: CANCER RESEARCH. 2018;78(20):5901-5916
- Article: CELL CYCLE. 2018;17(17):2146-2163
- Article: ONCOTARGET. 2017;8(57):96536-96552
- Article: LEUKEMIA. 2017;31(1):213-221
- Article: SCIENTIFIC REPORTS. 2015;5:16495
- Article: LEUKEMIA. 2015;29(11):2221-2229
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2014;289(50):34601-34619
- Article: CANCER BIOLOGY & THERAPY. 2014;15(11):1499-1514
- Article: GENES & DEVELOPMENT. 2014;28(1):58-70
- Article: CELLS. 2012;1(4):774-798
- Article: PLOS ONE. 2012;7(12):e52476
- Article: BRITISH JOURNAL OF CANCER. 2011;104(11):1747-1754
- Article: PLOS ONE. 2011;6(4):e18303
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;405(4):581-587
- Article: JOURNAL OF ONCOLOGY. 2011;2011:852970-11
- Article: BIOCHEMISTRY RESEARCH INTERNATIONAL. 2011;2011:195209-16
- Article: CANCER CELL. 2010;18(3):231-243
- Article: PLOS ONE. 2010;5(3):e9578-A129
- Article: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2010;69(2):129-138
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2008;283(23):15568-15576
- Article: CANCER CELL. 2007;12(4):355-366
- Article: CELL CYCLE. 2007;6(4):434-437
- Article: MOLECULAR AND CELLULAR BIOLOGY. 2007;27(3):1056-1068
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2006;281(27):18463-18472
- Article: ACTA ONCOLOGICA. 2006;45(6):676-684
- Article: MODERN PATHOLOGY. 2005;18(5):629-637
- Article: CLINICAL CANCER RESEARCH. 2004;10(7):2407-2414
- Article: ONCOGENE. 2003;22(32):4993-5005
- Article: SEMINARS IN CANCER BIOLOGY. 2002;12(5):381-387
- Article: CANCER LETTERS. 2002;180(2):211-221
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2001;276(27):25336-25341
- Article: ONCOGENE. 2001;20(17):2171-2177
- Article: APOPTOSIS : AN INTERNATIONAL JOURNAL ON PROGRAMMED CELL DEATH. 2001;6(1-2):133-137
- Article: EXPERIMENTAL CELL RESEARCH. 2000;256(2):400-410
- Show more
All other publications
- Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
- Review: CELL DEATH AND DIFFERENTIATION. 2022;29(5):972-982
- Review: CANCERS. 2022;14(9):2126
- Corrigendum: ONCOGENE. 2021;40(32):5153
- Editorial comment: BIOSCIENCE REPORTS. 2019;39(7):BSR20190770
- Review: ONCOGENE. 2018;37(18):2351-2366
- Review: INTERNATIONAL JOURNAL OF ONCOLOGY. 2016;48(4):1313-1324
- Meeting abstract: CANCER RESEARCH. 2015;75:2082
- Conference publication: EUROPEAN JOURNAL OF CANCER. 2014;50:S72
- Book chapter: PROTEINS OF THE NUCLEOLUS. 2013;p. 251-273
- Review: CANCER AND METASTASIS REVIEWS. 2012;31(3-4):793-805
- Review: UPSALA JOURNAL OF MEDICAL SCIENCES. 2012;117(2):99-112
- Conference publication: CANCER RESEARCH. 2012;72:5560
- Conference publication: NEURO-ONCOLOGY. 2010;12:51
- Review: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2009;379(2):167-170
- Review: CELL BIOCHEMISTRY AND BIOPHYSICS. 2006;46(1):79-90
- Thesis / dissertation: 2004
- Book chapter: WILEY ENCYCLOPEDIA OF MOLECULAR MEDICINE. 2002;p.
Grants
Employments
- Researcher, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2015-
Degrees and Education
- Docent, Karolinska Institutet, 2012
- Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2004
- Master Of Medical Science, Karolinska Institutet, 1999
Supervisor
- Asimina Zisi, RNA Polymerase I inhibition: mechanism and exploitation in cancer treatment
- Kaveh Goudarzi, Functional investigation of prognostic biomarkers and therapeutic targets in glioma brain tumors
- Karl Holmberg Olausson, Molecular subclassification, stem cell markers and growth regulatory pathways in gliomas
- Inga Nazarenko, Modeling PDGF-driven gliomagenesis in the mouse
- Tamador Elsir, Transcription factors PROX1 and p53 in cancer development
Editorial work
- Tumor Discovery, Editorial board member, 2024
- Frontiers Biophysics, Section editor / academic editor, 2023
- Precision Cancer Medicine, AME HONG KONG, Editorial board member, 2023
- Cancers, Editorial board member, 2020